Top View
- (INN) for Biological and Biotechnological Substances
- Pathogenic Role of Immune Cells in Rheumatoid Arthritis: Implications in Clinical Treatment and Biomarker Development
- Belimumab Treatment for Adults with Systemic Lupus Erythematosus: a Review of Clinical Effectiveness, Cost- Effectiveness, and Guidelines
- 1. Rantalaiho V, Kautiainen H, Korpela M, Et Al. Targeted T
- WO 2018/013551 Al 18 January 2018 (18.01.2018) W !P O PCT
- Title of Presentation Arial 50Pt Bold
- New Treatment Options for Lupus Nephritis
- International Nonproprietary Names (INN) for Biological and Biotechnological Substances
- Lääkeaineiden Yleisnimet (INN-Nimet) 31.12.2019
- (BAFF) [Tabalumab] Standard Size, 200 Μg, Ab00958-10.0 View Online
- Monoclonal Antibodies in the Treatment of Multiple Myeloma: Current Status and Future Perspectives
- Biotechnology Presented by America’S Biopharmaceutical Research Companies
- Novelties in the Treatment of Rheumatoid Arthritis G.M
- 125521Orig1s000
- Biologic Therapies in Patients with Neuropsychiatric Systemic Lupus
- Review Article the Biological Disease-Modifying Antirheumatic Drugs and the Risk of Cardiovascular Events: a Systematic Review and Meta- Analysis
- New Strategies in Multiple Myeloma: Immunotherapy As a Novel Approach to Treat Patients with Multiple Myeloma Paola Neri1,2, Nizar J
- Steroid Sparing Effect: an Essential Element in Assessing Therapeutic Efficacy in SLE: Response to 'Time to Change the Primary
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- International Nonproprietary Names for Pharmaceutical Substances (INN)
- Looking for Therapeutic Antibodies in Next Generation Sequencing Repositories
- Lilly Discontinues Phase 3 Rheumatoid Arthritis Program for Tabalumab Based on Efficacy Results
- Esophagitis: Drugs Picture of Iron Pill Material in Biopsy TT’S Kodachrome 1St Page Folder Iron Medication Injury Medications/Drugs
- (INN) for Biological and Biotechnological Substances
- Valstybinės Vaistų Kontrolės Tarnybos Prie Lietuvos Respublikos Sveikatos Apsaugos Ministerijos Viršininkas
- THERAPEUTIC FOCUS Rheumatology Few Autoimmune Competitors Even Come Close to Commercial Stalwarts Humira, Enbrel and Remicade
- Download Curriculum Vitae
- Antibodies[Version 1; Peer Review: 2 Approved]
- Monoclonal Antibodies in Rheumatoid Arthritis
- International Nonproprietary Names (INN) for Biological and Biotechnological Substances
- Activating Factor Inhibitor, on Highly Sensitized Patients With
- Efficacy of Biological Disease-Modifying Antirheumatic Drugs: a Systematic Literature Review Informing the 2016 Update of the EU
- WO 2015/105926 Al 16 July 2015 (16.07.2015) P O PCT
- INN-Nimet 1 20.8.2019 a Abacavir Abacavirum Abakaviiri
- Quantify RA Clinical Outcomes Database